GOLDENWELL BIOTECH, INC. · Food and Kindred Products

GWLL

High riskNext report: Not enough history

View price ↗

The short version

A company still losing money with shrinking sales, with elevated risk.

Watch out for

Owes more than it owns (negative equity)
Losing money, losses are large next to sales
Revenue down 60.4% from the year before

Money moves

No insider buying or selling in the last 30 days

Facts from SEC filings, not a recommendation.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

Sep '23Tap a barJun '26

Last 12 months: $55.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

0/5Weak

MissDebt under half of equityNot relying on borrowed money.Owes more than it owns
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.Losses many times its sales
MissProfitable every yearSteady profits, not one good year.0 of 7 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$23K
MissGross margin 40%+Pricing power: sells for well above what it costs to make.21.8%

Revenue: $55; -60.4% vs prior year
Total debt: $176K
Free cash flow: -$23K; -41143.6% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: return on equity 15%+, share count not growing. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Revenue: $0
EPS: $0.00
Free cash flow: -$47K
Share count: 0.0%; vs a year ago

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 0.4
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

0.0%

Cash runwayAt last year's cash burn

6 months

Debt to equityLatest balance sheet: debt compared with what owners have

Owes more than it owns

Shares outstandingLatest reported

99M

Why high risk

Losing money, losses are large next to sales
About 6 months of cash left at its current burn
Owes more than it owns (negative equity)
Revenue down 60.4% from the year before
Auditor change
Past financials no longer reliable
Late quarterly report notice
Late annual report notice

Earnings reports

Last 0

Next reportNot enough history

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

New 5%+ holder (active)Oct 9 · View filing ↗Activist Auditor changeSep 29 · View filing ↗Watch Past financials no longer reliableMay 27 · View filing ↗Red flag Late quarterly report noticeMay 12 · View filing ↗Red flag Late annual report noticeMar 31 · View filing ↗Red flag

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

Leadership changeOct 9 · Form 8-K ↗New insiderOct 9 · Form 3 ↗New 5%+ holder (active)Oct 9 · Form SCHEDULE 13D ↗Auditor changeSep 29 · Form 8-K ↗Quarterly reportAug 14 · Form 10-Q ↗Annual reportJul 1 · Form 10-K ↗Quarterly reportJul 1 · Form 10-Q ↗Quarterly report (amended)Jun 29 · Form 10-Q/A ↗Quarterly report (amended)Jun 26 · Form 10-Q/A ↗Quarterly report (amended)Jun 26 · Form 10-Q/A ↗Past financials no longer reliableMay 27 · Form 8-K ↗Late quarterly report noticeMay 12 · Form NT 10-Q ↗Late annual report noticeMar 31 · Form NT 10-K ↗Quarterly reportDec 8, 2025 · Form 10-Q ↗Quarterly reportSep 12, 2025 · Form 10-Q ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page